Fortress Biotech, Inc. (NASDAQ:FBIOP) Sees Large Decrease in Short Interest

Fortress Biotech, Inc. (NASDAQ:FBIOP) saw a large drop in short interest in the month of March. As of March 31st, there was short interest totalling 4,800 shares, a drop of 14.3% from the March 15th total of 5,600 shares. Based on an average trading volume of 11,900 shares, the short-interest ratio is currently 0.4 days.

Fortress Biotech Trading Down 13.1 %

Shares of NASDAQ FBIOP opened at $15.22 on Tuesday. Fortress Biotech has a 52 week low of $6.40 and a 52 week high of $18.91. The firm has a 50-day moving average price of $15.88 and a 200 day moving average price of $13.38.

Fortress Biotech Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Tuesday, April 30th. Investors of record on Monday, April 15th will be paid a $0.1953 dividend. This represents a $2.34 annualized dividend and a dividend yield of 15.40%. The ex-dividend date is Friday, April 12th.

Fortress Biotech Company Profile

Fortress Biotech, Inc, a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino an oral minocycline drug for the treatment of moderate to severe acne; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Exelderm cream for antifungal intended for topical use; Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Amzeeq; Zilxi; and Accutane capsules for severe recalcitrant nodular acne.